AMAL vs PFBC

AMAL's Piotroski F-Score of 4/9 indicates a weak financial health profile, signaling potential operational inefficiencies or instability despite solid profitability metrics. The absence of an Altman Z-Score raises concern about default risk, especially given the lack of available leverage and liquidity data. While the stock trades below its intrinsic value of $80.65 and Graham Number of $45.21, suggesting undervaluation, the current price of $38.10 is significantly below both benchmarks, implying either deep value or market skepticism. Strong earnings growth (11.1% YoY) and consistent beat rates (3/4 in last 4 quarters) support future potential, but technical trends and insider selling undermine near-term momentum.

PFBC exhibits strong fundamental value, trading significantly below its Graham Number ($123.23) and Intrinsic Value ($307.1). While the Piotroski F-Score of 4/9 indicates stable but not exceptional financial health, the company boasts a high ROE of 17.21% and a consistent 25-quarter track record of earnings beats. Despite bearish insider sentiment and technical trends, the low P/E ratio of 9.07 and sustainable dividend payout make it an attractive value play.